These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 26204136

  • 1. Cholesterol Biosynthesis and Trafficking in Cortisol-Producing Lesions of the Adrenal Cortex.
    London E, Wassif CA, Horvath A, Tatsi C, Angelousi A, Karageorgiadis AS, Porter FD, Stratakis CA.
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3660-7. PubMed ID: 26204136
    [Abstract] [Full Text] [Related]

  • 2. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I, Lacroix A, Schürch W, Caron P, Antakly T, Stratakis CA.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome.
    Chen S, Li R, Lu L, Duan L, Zhang X, Tong A, Pan H, Zhu H, Lu Z.
    Endocrine; 2018 Jan; 59(1):183-190. PubMed ID: 29094256
    [Abstract] [Full Text] [Related]

  • 4. RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights.
    Di Dalmazi G, Altieri B, Scholz C, Sbiera S, Luconi M, Waldman J, Kastelan D, Ceccato F, Chiodini I, Arnaldi G, Riester A, Osswald A, Beuschlein F, Sauer S, Fassnacht M, Appenzeller S, Ronchi CL.
    J Clin Endocrinol Metab; 2020 Dec 01; 105(12):. PubMed ID: 32875319
    [Abstract] [Full Text] [Related]

  • 5. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
    Nomura K, Saito H, Aiba M, Iihara M, Obara T, Takano K.
    Endocr J; 2003 Apr 01; 50(2):155-62. PubMed ID: 12803235
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia.
    Liu S, Saloustros E, Berthon A, Starost MF, Sahut-Barnola I, Salpea P, Szarek E, Faucz FR, Martinez A, Stratakis CA.
    Endocr Relat Cancer; 2016 Jan 01; 23(1):15-25. PubMed ID: 26438728
    [Abstract] [Full Text] [Related]

  • 12. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
    Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA, Bourdeau I.
    Clin Endocrinol (Oxf); 2008 Sep 01; 69(3):367-73. PubMed ID: 18419788
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
    Hofland J, de Herder WW, Derks L, Hofland LJ, van Koetsveld PM, de Krijger RR, van Nederveen FH, Horvath A, Stratakis CA, de Jong FH, Feelders RA.
    Eur J Endocrinol; 2013 Jan 01; 168(1):67-74. PubMed ID: 23065993
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
    Almeida MQ, Stratakis CA.
    Mol Cell Endocrinol; 2011 Apr 10; 336(1-2):162-8. PubMed ID: 21111774
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor 2 (IGF2) expression in adrenocortical disease due to PRKAR1A mutations compared to other benign adrenal tumors.
    Nadella KS, Berthon A, Almeida MQ, Levy I, Faucz FR, Stratakis CA.
    Endocrine; 2021 Jun 10; 72(3):823-834. PubMed ID: 33420948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.